APA

Lee J., Jung K. H., Park Y. S., Ahn J. B., Shin S. J., Im S., Oh D. Y., Shin D. B., Kim T. W., Lee N., Byun J. H., Hong Y. S., Park J. O., Park S. H., Lim H. Y. & Kang W. K. (20090817). Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. : Cancer chemotherapy and pharmacology.

Chicago

Lee Jeeyun, Jung Kyung Hae, Park Young Suk, Ahn Joong Bae, Shin Sang Jun, Im Seock-Ah, Oh Do Youn, Shin Dong Bok, Kim Tae Won, Lee Namsu, Byun Jae Ho, Hong Yong Sang, Park Joon Oh, Park Se Hoon, Lim Ho Yeong and Kang Won Ki. 20090817. Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. : Cancer chemotherapy and pharmacology.

Harvard

Lee J., Jung K. H., Park Y. S., Ahn J. B., Shin S. J., Im S., Oh D. Y., Shin D. B., Kim T. W., Lee N., Byun J. H., Hong Y. S., Park J. O., Park S. H., Lim H. Y. and Kang W. K. (20090817). Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. : Cancer chemotherapy and pharmacology.

MLA

Lee Jeeyun, Jung Kyung Hae, Park Young Suk, Ahn Joong Bae, Shin Sang Jun, Im Seock-Ah, Oh Do Youn, Shin Dong Bok, Kim Tae Won, Lee Namsu, Byun Jae Ho, Hong Yong Sang, Park Joon Oh, Park Se Hoon, Lim Ho Yeong and Kang Won Ki. Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study. : Cancer chemotherapy and pharmacology. 20090817.